These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24195129)

  • 1. No adverse--or beneficial--effect of HRT on cognitive function in younger postmenopausal women.
    Brown S
    Menopause Int; 2013 Sep; 19(3):104-5. PubMed ID: 24195129
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone therapy in younger women and cognitive health.
    Grodstein F
    JAMA Intern Med; 2013 Aug; 173(15):1437-8. PubMed ID: 23797264
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years.
    Espeland MA; Shumaker SA; Leng I; Manson JE; Brown CM; LeBlanc ES; Vaughan L; Robinson J; Rapp SR; Goveas JS; Wactawski-Wende J; Stefanick ML; Li W; Resnick SM;
    JAMA Intern Med; 2013 Aug; 173(15):1429-36. PubMed ID: 23797469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen research. Brain researchers try to salvage estrogen treatments.
    Wickelgren I
    Science; 2003 Nov; 302(5648):1138-9. PubMed ID: 14615509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate].
    Ortmann J; Traupe T; Vetter W; Barton M
    Praxis (Bern 1994); 2004 May; 93(21):904-14. PubMed ID: 15216975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minireview: effects of different HT formulations on cognition.
    Maki PM
    Endocrinology; 2012 Aug; 153(8):3564-70. PubMed ID: 22673228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous HRT with oestrogen plus progestogen is linked to reduced risk of endometrial cancer.
    Mayor S
    BMJ; 2015 Dec; 351():h6627. PubMed ID: 26645093
    [No Abstract]   [Full Text] [Related]  

  • 12. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormones: where do we go from here?
    Harv Womens Health Watch; 2003 Jan; 10(5):3-4. PubMed ID: 12543588
    [No Abstract]   [Full Text] [Related]  

  • 14. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
    Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
    Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination hormone therapy tied to slight increase in breast cancer deaths.
    Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re.: Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative Hormone Therapy Trials.
    Assimos D
    J Urol; 2011 May; 185(5):1749-50. PubMed ID: 22088708
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive effects of estrogens in women with cardiac disease: what we do not know.
    Sano M; Bell K; Jacobs D
    Am J Med; 2002 Nov; 113(7):612-3. PubMed ID: 12459411
    [No Abstract]   [Full Text] [Related]  

  • 19. NIH workshop tries to create consensus on HRT use.
    Randal J
    J Natl Cancer Inst; 2003 Jan; 95(1):9-11. PubMed ID: 12509392
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone replacement therapy in menopause].
    Breckwoldt M
    Dtsch Med Wochenschr; 2003 Feb; 128(8):400. PubMed ID: 12594630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.